The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in ... New Study Finds a ...

Richard Cohen, the journalist husband of broadcaster Meredith Vieira, has died at 76, more than 50 years after an MS ...

BC, MSCN has joined the Memory Clinic staff. Penny is board-certified in Family Practice with focused training in certain ...

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in ... New Study Finds a ...

ANK-700 is under clinical development by Anokion and currently in Phase I for Relapsing Remitting Multiple Sclerosis (RRMS).

Most MS treatments don't increase the risk for miscarriage or major birth defects when used during pregnancy, an analysis ...

The blood-brain barrier (BBB) is a major hurdle for the development of systemically delivered drugs targeting diseases of the central nervous system (CNS). Because of this barrier there is a huge ...

Memorial University researcher Michelle Ploughman says artificial intelligence can analyze health data in ways people can't, ...

The most-read stories published by Multiple Sclerosis News Today in 2024 focused on living with MS and news on disease risk factors.

Now, scientists at Stanford University have found that a faulty genetic molecule could be responsible for the immune system misidentifying healthy tissue as a threat. The breakthrough study, published ...

INR:8125. pkl final winners list Science sub-journal: Old drugs for multiple sclerosis can also treat brain cancer Zejing's new drug is approved for clinic ...